A fortune.
You wouldn't sell prior to approval.
The product is estimating to generate around $225 million in revenue annually through the USA alone.
This is game changing based on scripts in established overseas markets.
Then you add P/E multiples against these figures and the numbers are mind blowing.
Botanix knows this is game changing, they wouldn't just give this away.
Even currently selling this under a billion dollars is a crime.
A fortune.You wouldn't sell prior to approval.The product is...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 33.0¢ | $2.271M | 6.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83805 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 112605 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |